Bellevue Group Ag Procept Bio Robotics Corp Transaction History
Bellevue Group Ag
- $5.02 Billion
- Q4 2024
A detailed history of Bellevue Group Ag transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bellevue Group Ag holds 462,894 shares of PRCT stock, worth $28.8 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
462,894
Previous 612,691
24.45%
Holding current value
$28.8 Million
Previous $49.1 Million
24.06%
% of portfolio
0.74%
Previous 0.83%
Shares
12 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$217 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$109 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$92.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$75.1 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.78B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...